Plain-English translation of ·
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing a new medication called to see if it can treat a type of bladder cancer that hasn't spread into the muscle layer of the bladder. The medication will be injected directly into your bladder, and depending on which part of the study you join, you may receive it alone or combined with other treatments. Researchers want to learn how safe this medication is, how your body handles it, and whether it can help stop cancer from coming back.
Many people with this type of bladder cancer don't respond well to standard treatments like (a common immunotherapy), and some patients can't have surgery to remove their bladder. This trial exists to find a new option for people in these situations.
You likely qualify if…
You likely don't qualify if…
You will receive injections of the medication directly into your bladder on specific days in a repeating 21-day cycle. Depending on which part of the study you join, you may also receive other injections under your skin. Treatment will continue for up to about 2 years, or until you and your doctor decide to stop. You will have regular visits to your doctor to check how you're doing and monitor for any side effects.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
United States